close Video

NEW You can now listen to Fox News articles!

Weight-loss drugs continue to grow in popularity, with market researchers predicting that global demand for the medications could reach $150 billion by 2035.

GLP-1 agonists — including semaglutides like Ozempic and Wegovy and tirzepatides like Mounjaro and Zepbound — are intended to treat type 2 diabetes and obesity.

Recent studies, however, have linked these medications to additional benefits, such as a reduction in heart disease and dementia risk, as doctors recommend them to a growing number of patients.

SCIENTISTS MAY HAVE DISCOVERED WHY THE POUNDS COME BACK AFTER LOSING WEIGHT

Even so, recent Yale research found that only 3% of eligible adults received a prescription.

Who should take weight-loss drugs?

Most adult

See Full Page